NLARx News
State Legislators at Annual Summit Urge Federal Action to Regulate Excessive Marketing of Pharmaceuticals More
Body Representing All U.S. State Legislatures Moves to Endorse Public Health Insurance More
|
In the States
NEW HAMPSHIRE: State Passes Law to Protect the Privacy of Personal Health Information More
ILLINOIS: Baxter Settles Inflated Prices Lawsuit for $6.8 Million More
WISCONSIN: Attorney General Van Hollen Announces Pharmaceutical Settlement More
KENTUCKY: Reaches $2 Million Settlement with Drug Company More
MASSACHUSETTS: Two Local Biotech Firms Bankrupt
More |
Prices and Access to Healthcare
President, House Agitate For More Drug Cuts MoreHouse Bill Includes $50B Drug-Price Rebates MoreComparative Effectiveness Research Underway At 28 Research Centers MoreDebate Surrounds The Merits Of Comparative Effectiveness Research MorePharma Subsidies Erode Utility Of Co-Pays More |
Patents and Generics
Lobbyists Battle Over Biologic Drug Protections More
Costly Drugs Known as Biologics Prompt Exclusivity Debate More
Analysts: Amgen Most At Risk From Biogenerics More
Biotech Bottleneck More
Dangerous Side Effects More
|
Conflicts of Interest
University of Minnesota Surgeon's Deals with Medtronic Draw Fire More
American Medical Student Association Rejects New Organization Dedicated to Limiting Conflict of Interest Regulation More
Senator Grassley Release on Transparency in Financial Ties Between Doctors and Industry More
|
Advertising and Marketing
Under Settlement, FDA To Pre-approve Merck Ads More
Judge Scolds Schering For Off-Label Shilling More
Lilly Nears Another Zyprexa Settlement More
Lilly Moves Closer to Another Deal Over Zyprexa Marketing More
Lawmakers Take Aim at Direct to Consumer Ads More
Sales Reps See Scaled-Back Incentive Pay More
The Changing Landscape of Pharmaceutical Marketing More
When Drug Companies Use Assistance Programs As Marketing Tools More
When is it Acceptable for Pharma Marketers to Use Behavioral Targeting? More
A New Era of Pharma Marketing: Direct to Journalist (DTJ) More
|
Pharma Watch
Drugmakers May Fund $100 Million Ad Campaign on Health Overhaul More
PhRMA's Tally: $40 Million To Lobby On Health Care More
Industry Donates To Drug Plan Foes More
Health Care Industry Unleashing Big Money More
The Way Pharma Lives Now: Bristol's $2.1 Billion Medarex Deal More
Will Merck Partner On Consumer Health? Will Singulair Go OTC? More
Amgen, GSK to Launch Joint Sales Attack for Bone Drug More
Emerging Markets Figure In Glaxo-Amgen Deal More
The Philippines, Pfizer and Pharma's Global Growing Pains More
Strong Dollar Beats Down Pharma Revenues More
Big Pharma Gets Played More
|
PBM Watch
Drug Makers Circumvent Co-Pays Using Rebates - Shift Costs to Insurers More
Aetna Shops PBM Services, Cuts Earnings Outlook More
CVS Might Bid for Aetna's PBM Division More
|
Medicare and Medicaid
Democratic Senators Propose Medicare Drug Rebates More
New Study Finds Positive Developments, Persistent Problems In Medicare Drug Plan More
Medicare Part D Update - Lessons Learned and Unfinished Business More
CBO Fears Providers Will Control "MedPAC on Steroids" More
Medicare Fraud Taints California Device Maker And New Jersey Clinic More
|
Electronic Records
Federal Advisory Panel Wants Privacy Protection for Electronic Medical Records MoreHow to Keep Electronic Health Records Secure MoreWest Virginia Health Care Providers Discuss Electronic Records MoreElectronic Medical Records: One Doctor's View More |
Safety and Clinical Trials
Pfizer Faces First Neurontin Court Fight MoreStatins Get Boost from New Study MoreGAO: Food and Drug Administration Can't Estimate Its Own Budget Needs MoreStudy: 'Accelerated' FDA Approval Too Slow for Cancer Drugs MoreMerck, Schering Settle Vytorin Claims For $5.4M MoreOther Probes Still On after State AGs Settle with Merck and Schering-Plough MoreStudy Using Viagra Ingredient to Treat Sickle Cell Cut Short MoreMylan Says It's in the Clear With FDA. FDA Disagrees More |
